Padeliporfin VTP Using Robotic Assisted Bronchoscopy in Peripheral Lung Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 28, 2025

Primary Completion Date

May 30, 2027

Study Completion Date

December 30, 2028

Conditions
Peripheral Lung Tumor
Interventions
COMBINATION_PRODUCT

Padeliporfin Vascular Targeted Photodynamic (VTP) therapy

Bronchoscopy will be performed with robotic assisted approach using standard practices using general anaesthesia and placement of the optic fiber intratumorally followed by IV administration of Padeliporfin for 10 min and laser light illumination.

Trial Locations (1)

21224

RECRUITING

Johns Hopkins University School of Medicine, Baltimore

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Impact Biotech Ltd

INDUSTRY

NCT05918783 - Padeliporfin VTP Using Robotic Assisted Bronchoscopy in Peripheral Lung Cancer | Biotech Hunter | Biotech Hunter